Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Smoking Cessation 2Weight Gain 1Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Secondary Prevention × Clear all
NCT01352000 2017-02-23

Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
3,830 enrolled

Smoking Cessation

NCT01305447 2014-12-16

Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention

University of Western Ontario, Canada

Phase 2 Completed
413 enrolled

Neoplasms, Weight Gain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡